کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3194998 | 1201419 | 2008 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
امراض پوستی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety](/preview/png/3194998.png)
چکیده انگلیسی
Efalizumab is a humanized monoclonal antibody directed against the CD11a subunit of the lymphocyte function-associated antigen 1. It has been approved for the treatment of moderate-to-severe plaque psoriasis. Efalizumab has been shown in several clinical trials to be effective and well tolerated in the treatment of patients with moderate-to-severe psoriasis. The safety profile of continuous therapy with efalizumab-as far as it is currently available-is favorable. Mode of action, pharmacological profile, clinical indications and efficacy, safety, and tolerability as well as practical considerations of efalizumab are reviewed in this article.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinics in Dermatology - Volume 26, Issue 5, SeptemberâOctober 2008, Pages 509-514
Journal: Clinics in Dermatology - Volume 26, Issue 5, SeptemberâOctober 2008, Pages 509-514
نویسندگان
Michael P. MD,